Balaxi Pharma gets WHO-GMP certification for manufacturing facility

Balaxi Pharma gets WHO-GMP certification for manufacturing facility. This certification enables the company to export generic drugs to international markets regulated by the WHO. The facility clearance is a key step toward global market expansion. No financial figures were disclosed in the filing.

📊 STOCKS: $BALAXI | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Regulatory